Clinical Trials Logo

Clinical Trial Summary

The investigators' central hypotheses predict that the handheld spirometry device will be feasible for inpatient and at-home use, and is equally efficacious at determining lung function when compared to traditional, bedside spirometry measurements. To test these hypotheses, the investigators propose the following specific aims:

Specific Aim 1: Determine the correlation of SpiroPD handheld spirometry measurements with bedside Koko spirometry lung function.

Hypothesis: Correlation between the two lung function tests will be substantial for both hospitalized and ambulatory patients.

Specific Aim 2: To determine the feasibility, adherence, and preliminary management efficacy of home SpiroPD testing.

Hypotheses: (1) Patients will demonstrate substantial adherence to daily home spirometry testing; (2) medication adherence will increase significantly in patients who are adherent to daily home spirometry testing; (3) acute care utilization will decrease significant in adherent patients.


Clinical Trial Description

Chronic Obstructive Pulmonary Disease (COPD) results in nearly 750,000 hospitalizations annually and is the third leading cause of "early" (within 30-day) hospital readmissions in the United States. Curbing preventable early readmissions for acute exacerbations of COPD (AECOPD) has become a national priority, as demonstrated by the Medicare Hospital Readmissions Reduction financial penalty program. One critical barrier in assessing readmission risk is the lack of an easily-measured 'vital sign' for COPD: accurate, timely measurements of lung function. Unlike other medical problems that have validated, easily-obtained measurements of organ function, COPD evaluation often defaults to patient report and physician evaluation without critical physiologic data. This lack of objective pulmonary function data during AECOPD in turn leads to critical errors in disease severity assessment. However, the required, repeated measurements by spirometry that can demonstrate responses to therapy can be time-consuming and expensive to perform in a laboratory, and both equipment and staffing infrastructure for bedside testing is cumbersome and often not prioritized. For these reasons, spirometry frequently is not done for patients with AECOPD.

To monitor patient responses to therapy and to assess risks based on objective measures, the investigators propose to the study the use of a portable, patient-driven device ("SpiroPD") that can be used in both in-patient and outpatient settings, and that reports (via the internet) values collected in real time. While the device has been used in the lung transplant community and for patients with cystic fibrosis, no studies have been done to validate its use in COPD. This protocol involves in-hospital patient training with the device followed by serial measurements at home in the first 30 days post hospital-discharge.

Demonstration in a pilot, single-center trial of the usefulness of real-time, repeated hand-held spirometry to provide objective measurements of lung function in AECOPD will have a substantial impact on both patient health outcomes and on health care utilization and will set the stage for appropriate next-step studies and NIH grant applications. It is unknown whether this specific technology will be acceptable in the target population, though previous research suggests that older patients may be more willing to use home monitoring technology. This multi-disciplinary research team includes providers from the Department of Medicine and the UCM COPD Readmissions Program team. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03284203
Study type Interventional
Source University of Chicago
Contact Mary Akel
Phone 7738344489
Email makel@medicine.bsd.uchicago.edu
Status Recruiting
Phase N/A
Start date September 30, 2017
Completion date March 1, 2019

See also
  Status Clinical Trial Phase
Not yet recruiting NCT03503123 - Deventilation Dyspnea in COPD Patients Using NIV
Completed NCT02536508 - Study to Assess the Safety and Tolerability of PT010, PT009 and PT003 in Subjects With Moderate to Very Severe Chronic Obstructive Pulmonary Disease Phase 3
Enrolling by invitation NCT03468101 - Characterization of Professional COPD Related to Exposure to Organic Dust - Mean Follow up at 6 Years
Not yet recruiting NCT03611036 - Effect of Different Form of Upper Limb Muscles Training on Dyspnea in COPD N/A
Not yet recruiting NCT03229473 - Fall Risk Assessment in COPD N/A
Not yet recruiting NCT03278795 - VSV Versus PSV as a Weaning Mode of Mechanically Ventilated Chronic Obstructive Pulmonary Disease Patients N/A
Recruiting NCT02815683 - Bronchoscopic EmphysemA Treatment in THE NetherLands N/A
Not yet recruiting NCT02914093 - IMT in Hypercapnic Patients With COPD N/A
Not yet recruiting NCT02881385 - Effects on Respiratory Patterns and Patient-ventilator Synchrony Using Pressure Support Ventilation N/A
Recruiting NCT02807025 - Nasal, Tracheal and Bronchial Mucosal Lining Fluid(MLF) Sampling From Patients With Respiratory Diseases N/A
Recruiting NCT02515318 - Physiotherapy in Acute Exacerbation of Chronic Obstructive Pulmonary Disease N/A
Completed NCT03028701 - Assessment of Bronchodilator Efficacy of Formoterol/Budesonide 12/400 mcg Via Discair in COPD Phase 4
Completed NCT02750189 - The Economic Burden of Chronic Obstructive Pulmonary Disease(COPD) in South Korea N/A
Completed NCT02517411 - Physiotherapy in Patients With Stable Chronic Obstructive Pulmonary Disease N/A
Completed NCT02509299 - Effect of Physiotherapy on Perceived Health Status in Hospitalized COPD Patients N/A
Recruiting NCT02236039 - COPD Originates in Polluted Air N/A
Recruiting NCT03026439 - Searching Chronic Obstructive Pulmonary Disease Onset N/A
Recruiting NCT02735954 - Colorado Marijuana Users Health Cohort N/A
Recruiting NCT01892566 - Using Mobile Health to Respond Early to Acute Exacerbations of COPD in HIV N/A
Recruiting NCT02223780 - Early Palliative Care for Patients With Severe and Very Severe COPD: a Randomised Study N/A